Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques

Molyneux, P. D.; Tofts, P. S.; Fletcher, A.; Gunn, B.; Robinson, P.; Gallagher, H.; Moseley, I. F.; Barker, G. J.; Miller, D. H.
July 1998
Journal of Neurology, Neurosurgery & Psychiatry;Jul1998, Vol. 65 Issue 1, p42
Academic Journal
journal article
No abstract available.


Related Articles

  • Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy. Stevenson, Valerie L.; Smith, Stephen M.; Matthews, Paul M.; Miller, David H.; Thompson, Alan J. // Journal of Neurology;Feb2002, Vol. 249 Issue 2, p171 

    Objective To explore the potential usefulness of two new magnetic resonance imaging (MRI) analysis techniques for assessment of progressive cerebral atrophy and T2 lesion activity in primary progressive multiple sclerosis (PPMS), and thereby assess the relationship between MRI activity and...

  • Examination of the role of magnetic resonance imaging in multiple sclerosis: A problem-orientated approach. McFarland, Henry F. // Annals of Indian Academy of Neurology;Oct-Dec2009, Vol. 12 Issue 4, p254 

    Magnetic Resonance Imaging (MRI) has brought in several benefits to the study of Multiple Sclerosis (MS). It provides accurate measurement of disease activity, facilitates precise diagnosis, and aid in the assessment of newer therapies. The imaging guidelines for MS are broadly divided in to...

  • Can Lesion Volume and Brain Atrophy Predict Outcomes in Early MS? Karon, Amy // Neurology Reviews;Sep2014, Vol. 22 Issue 9, p41 

    The article discusses a research study published in the July 23, 2014 issue of the journal "Multiple Sclerosis and Related Disorders," which examined the potential of lesion volume and brain atrophy, measured by magnetic resonance imaging (MRI), to predict outcomes in early multiple sclerosis...

  • Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. Inglese M; Mancardi G L; Pagani E; Rocca M A; Murialdo A; Saccardi R; Comi G; Filippi M; Inglese, M; Mancardi, G L; Pagani, E; Rocca, M A; Murialdo, A; Saccardi, R; Comi, G; Filippi, M; Italian GITMO-NEURO Group on Autologous Hematopoietic Stem Cell Transplantation // Journal of Neurology, Neurosurgery & Psychiatry;Apr2004, Vol. 75 Issue 4, p643 

    To assess whether brain tissue loss occurs after profound and sustained suppression of magnetic resonance imaging (MRI) enhancement, we measured brain volume changes from 10 patients with rapidly evolving secondary progressive multiple sclerosis (MS) treated with autologous haematopoietic stem...

  • Has your patient's multiple sclerosis lesion burden or brain atrophy actually changed? Wei, Xingchang; Guttmann, Charles R. G.; Warfield, Simon K.; Eliasziw, Michael; Mitchell, J. Ross // Multiple Sclerosis (13524585);Aug2004, Vol. 10 Issue 4, p402 

    Changes in mean magnetic resonance imaging (MRI)-derived measurements between patient groups are often used to determine outcomes in therapeutic trials and other longitudinal studies of multiple sclerosis (MS). However, in day-to-day clinical practice the changes within individual patients may...

  • A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis. Brex, Peter A.; Ciccarelli, Olga; O'Riordan, Jonathon I.; Sailer, Michael; Thompson, Alan J.; Miller, David H. // New England Journal of Medicine;1/17/2002, Vol. 346 Issue 3, p158 

    Background: In patients with isolated syndromes that are clinically suggestive of multiple sclerosis, such as optic neuritis or brain-stem or spinal cord syndromes, the presence of lesions as determined by T2-weighted magnetic resonance imaging (MRI) of the brain increases the likelihood that...

  • A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis. Furby, J.; Hayton, T.; Altmann, D.; Brenner, R.; Chataway, J.; Smith, K.; Miller, D.; Kapoor, R. // Journal of Neurology;Sep2010, Vol. 257 Issue 9, p1508 

    MRI measures of tissue atrophy within the central nervous system may reflect the neurodegenerative process which underpins the progressive phase of multiple sclerosis (MS). There has been limited longitudinal investigation of MRI-detected atrophy in secondary progressive MS. This study includes...

  • The use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials. Boneschi, Filippo Martinelli; Rovaris, Marco; Comi, Giancarlo; Filippi, Massimo // Multiple Sclerosis (13524585);Aug2004, Vol. 10 Issue 4, p341 

    Magnetic resonance imaging (MRI) is an important paraclinical tool for the diagnosis of multiple sclerosis (MS) and for monitoring its disease course. The efficacy of most of the available MS disease-modifying treatments has been tested in clinical trials where MRI-derived quantities served as...

  • MRI Correlates of Disability in African-Americans with Multiple Sclerosis. Howard, Jonathan; Battaglini, Marco; Babb, James Scott; Arienzo, Donatello; Holst, Brigitte; Omari, Mirza; De Stefano, Nicola; Herbert, Joseph; Inglese, Matilde; Villoslada, Pablo // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Objectives: Multiple sclerosis (MS) in African-Americans (AAs) is characterized by more rapid disease progression and poorer response to treatment than in Caucasian-Americans (CAs). MRI provides useful and non-invasive tools to investigate the pathological substrate of clinical progression....

  • Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study. Schmierer, Klaus; Altmann, Daniel R.; Kassim, Nadja; Kitzler, Hagen; Kerskens, Christian M.; Doege, Claudia A.; Aktas, Orhan; L√ľnemann, Jan D.; Miller, David H.; Zipp, Frauke; Villringer, Arno // Multiple Sclerosis (13524585);Apr2004, Vol. 10 Issue 2, p182 

    In spite of marked disability, patients with primary progressive multiple sclerosis (PPMS) display smaller lesion volumes on conventional magnetic resonance imaging (MRI) compared with other forms of multiple sclerosis (MS). Hence, damage to the normal-appearing brain tissue (NABT) may play an...


Read the Article


Sign out of this library

Other Topics